Beijing Jinhao Pharmaceutical

Beijing Jinhao Pharmaceutical is a China-based healthcare company focused primarily on diagnostic reagents, related biotechnological products, and associated pharmaceutical and medical-device manufacturing. Public business-registry descriptions characterize the company as a high-tech enterprise with GMP manufacturing facilities in Beijing and a product portfolio spanning infectious disease, oncology, and biochemical in vitro diagnostic products. The company also appears to have conducted some proprietary biologics-related R&D, including patent activity around modified fibroblast growth factor 21 proteins, but available public evidence does not show a broad disclosed therapeutic clinical pipeline. Its business profile is therefore best understood as a commercially active diagnostics and healthcare manufacturing company rather than a venture-stage therapeutic biotech. The company is privately held and non-listed.